Of the trio involved in the above-mentioned “signalosome”, high GSTP1 expression levels have in fact been reported in diverse human malignancies including breast, colon and ovarian cancer, and an involvement of GSTP1 in tumorigenesis and drug resistance in general has long been recognized [53, 54]. Here, GSTP1 is linked to ovarian cancer.